Considerations when measuring myocardial perfusion reserve by cardiovascular magnetic resonance using regadenoson
about
Cardiac MRI assessment of myocardial perfusion.Advances in stress cardiac MRI and computed tomography.Review of Journal of Cardiovascular Magnetic Resonance 2012.Review of Journal of Cardiovascular Magnetic Resonance 2013Safety and tolerability of regadenoson CMR.Risk stratification by regadenoson stress magnetic resonance imaging in patients with known or suspected coronary artery diseaseQuantitative Perfusion Analysis of First-Pass Contrast Enhancement Kinetics: Application to MRI of Myocardial Perfusion in Coronary Artery Disease.Regadenoson and adenosine are equivalent vasodilators and are superior than dipyridamole- a study of first pass quantitative perfusion cardiovascular magnetic resonance.Prognostic value of normal regadenoson stress perfusion cardiovascular magnetic resonance.Assessment of global myocardial perfusion reserve using cardiovascular magnetic resonance of coronary sinus flow at 3 Tesla.Regadenoson stress for myocardial perfusion imaging.Current perspectives in coronary microvascular dysfunction.Update on Computed Tomography Myocardial Perfusion Imaging.Estimating extraction fraction and blood flow by combining first-pass myocardial perfusion and T1 mapping results.Prognostic Value of Quantitative Stress Perfusion Cardiac Magnetic Resonance.Rapid rest/stress regadenoson ungated perfusion CMR for detection of coronary artery disease in patients with atrial fibrillation.Quantitative cardiovascular magnetic resonance perfusion imaging identifies reduced flow reserve in microvascular coronary artery disease.
P2860
Q30407701-55A3567F-A164-4934-8D62-2334A50EEFE4Q30412128-663356AE-2E16-40F1-BB1E-696D9CB57E3AQ30446298-7D765333-9068-4C0B-8279-30E52176B8D5Q30487473-17C98CE8-4981-4CB6-84E5-365F62FD0C8CQ33767994-B848F5D8-7153-4E11-9E8C-F7848DCABB02Q35235410-63E73503-6A74-4E46-BB77-84DC4D7F31AAQ36119540-F004276A-0E14-4DEF-AC9A-41A458A0AABFQ37364858-B5E55917-E051-48B3-AB18-A8060DCA6E1FQ37425510-DAB431B2-0D51-46F6-A09E-D9DFD060A8BCQ37688871-7362FA0D-9609-4EA2-9AC6-90A9EFF2FDCCQ38660349-9F1635C6-85DB-42FA-A1B0-999582A3AC92Q39038913-2EE97DAA-D8BF-41F8-85A6-5F8D4E9F312EQ41868187-2B10E4AC-4666-4E37-B535-AAEA2B7C853DQ46518503-0418309F-39E6-4E36-BE6C-5EE496CBD059Q47334138-E934F68A-4F59-4D1B-9A69-1C5613EA7836Q50633361-2CD6D6B3-5220-4BBB-9D6C-5A9CC2E92C65Q55192973-597DB2FB-327E-456C-AB0E-30D7E3928A04
P2860
Considerations when measuring myocardial perfusion reserve by cardiovascular magnetic resonance using regadenoson
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Considerations when measuring ...... ic resonance using regadenoson
@ast
Considerations when measuring ...... ic resonance using regadenoson
@en
type
label
Considerations when measuring ...... ic resonance using regadenoson
@ast
Considerations when measuring ...... ic resonance using regadenoson
@en
prefLabel
Considerations when measuring ...... ic resonance using regadenoson
@ast
Considerations when measuring ...... ic resonance using regadenoson
@en
P2093
P2860
P356
P1476
Considerations when measuring ...... ic resonance using regadenoson
@en
P2093
Benjamin H Freed
Chattanong Yodwut
Denise Kolanczyk
Karin Dill
Nicole M Bhave
Roberto M Lang
P2860
P2888
P356
10.1186/1532-429X-14-89
P577
2012-12-28T00:00:00Z
P6179
1039100490